Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Beijing Chunlizhengda Medical Instruments Co., Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
2
Flat results in Jun 22
3
With ROE of 4.11%, it has a Very Expensive valuation with a 0.46 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 72.23%, its profits have fallen by -56.7%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Beijing Chunlizhengda Medical Instruments Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Beijing Chunlizhengda Medical Instruments Co., Ltd.
71.27%
1.17
54.87%
Hang Seng Hong Kong
27.36%
1.03
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
17.08%
EBIT Growth (5y)
68.23%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
0.41
Tax Ratio
6.13%
Dividend Payout Ratio
40.98%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.42%
ROE (avg)
8.74%
Valuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.46
EV to EBIT
-6.38
EV to EBITDA
-4.61
EV to Capital Employed
-0.44
EV to Sales
-0.59
PEG Ratio
NA
Dividend Yield
0.91%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
4.11%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Beijing Chunlizhengda Medical Instruments Co., Ltd.
Raw Material Cost
Fallen by -6.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






